Crestwood Advisors Group LLC Abbott Laboratories Transaction History

Crestwood Advisors Group LLC

$4.5 Billion
Q1 2024

A detailed history of Crestwood Advisors Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 88,773 shares of ABT stock, worth $9.06 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

88,773

Previous 79,999 10.97%

Holding current value

$9.06 Million

Previous $8.81 Million 14.58%

% of portfolio

0.22%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $960,928 - $1.06 Million	8,774 Added 10.97%	88,773 $10.1 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $113,188 - $138,552	1,255 Added 1.59%	79,999 $8.81 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $88,651 - $106,367	-928 Reduced 1.16%	78,744 $7.63 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $3.18 Million - $3.54 Million	-31,533 Reduced 28.36%	79,672 $8.69 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $918,329 - $1.08 Million	-9,481 Reduced 7.86%	111,205 $11.3 Million

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $35,932 - $42,154	378 Added 0.31%	120,686 $13.3 Million
Q3 2022 Oct 26, 2022	BUY	$96.76 - $112.03 $94,921 - $109,901	981 Added 0.82%	120,308 $11.6 Million
Q2 2022 Jul 07, 2022	BUY	$102.07 - $123.37 $289,980 - $350,494	2,841 Added 2.44%	119,327 $13 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $102,503 - $124,996	-899 Reduced 0.77%	116,486 $13.8 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $94,965 - $116,280	822 Added 0.71%	117,385 $16.5 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $21,582 - $23,876	-185 Reduced 0.16%	116,563 $13.8 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $90,027 - $105,975	851 Added 0.73%	116,748 $13.5 Million
Q1 2021 Apr 21, 2021	SELL	$108.84 - $128.23 $10,230 - $12,053	-94 Reduced 0.08%	115,897 $13.9 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $225,225 - $245,430	-2,145 Reduced 1.82%	115,991 $12.7 Million
Q3 2020 Oct 06, 2020	BUY	$91.64 - $111.29 $69,646 - $84,580	760 Added 0.65%	118,136 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $587,291 - $751,660	7,670 Added 6.99%	117,376 $10.7 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $236,580 - $345,944	-3,766 Reduced 3.32%	109,706 $8.66 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $18,057 - $20,102	-230 Reduced 0.2%	113,472 $9.86 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $26,434 - $28,663	323 Added 0.28%	113,702 $9.51 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $8.26 Million - $9.64 Million	113,379 New	113,379 $9.54 Million

Others Institutions Holding ABT

# of Institutions

3,118

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Account

Crestwood Advisors Group LLC Abbott Laboratories Transaction History